Picture of Avidity Biosciences logo

RNA — Avidity Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Press Digest: Wall Street Journal - October 27

The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

- Novartis NOVN.S is acquiring Avidity Biosciences RNA.O in a $12 billion deal that the Swiss drugmaker said would further boost its long-term focus on treating neuromuscular disorders.

- Roughly 3,200 striking St. Louis-area Boeing BA.N workers will stay on the picket line after members rejected a modified contract proposal for a fourth time.

- Australia's consumer watchdog is suing Microsoft MSFT.O, alleging the U.S. tech giant misled its 2.7 million customers by making it difficult for them to avoid paying for new artificial-intelligence services.

- HSBC Holdings HSBA.L is booking a provision of $1.1 billion for a lawsuit in Luxembourg related to Bernard Madoff's multibillion-dollar Ponzi scheme, one of the largest financial frauds in American history.

- The U.S. will impose an additional 10% tariff on Canada, President Donald Trump said on Saturday, a punitive measure in response to an ad campaign that he said misrepresented comments by former President Ronald Reagan.

- Movie and television producer Taylor Sheridan, known for hits including "Yellowstone," "Tulsa King" and "Landman," has signed a deal to join NBCUniversal CMCSA.O after his contract with Paramount PSKY.O expires.

 (Compiled by Bengaluru newsroom)

 ((globalnewsmonitoring@thomsonreuters.com))

Recent news on Avidity Biosciences

See all news